This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Shunichi Yamaguchi: Innovator in Clinical Neurology
Introduction
Shunichi Yamaguchi is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of clinical neurology, particularly in the treatment of epilepsy and drug addiction. His innovative work has led to the development of a unique compound that addresses critical health issues.
Latest Patents
Yamaguchi holds a patent for 5-aminocarbonyl-5H-dibenzo[a.d]cyclohepten-5,10-imines. This invention is specifically designed for the treatment of patients suffering from generalized epilepsy or partial (symptomatic) epilepsy. The compound is also aimed at helping individuals who are addicted to cocaine by addressing drug cravings.
Career Highlights
Yamaguchi's career is marked by his dedication to advancing medical treatments through innovative research. He works for the United States of America as represented by the Department of Health, where he continues to explore new therapeutic avenues.
Collaborations
Some of his notable coworkers include James A Monn and Andrew Y Thurkauf. Their collaborative efforts contribute to the ongoing research and development in the field of neurology.
Conclusion
Shunichi Yamaguchi's work exemplifies the impact of innovation in clinical neurology. His patent for a novel compound showcases his commitment to improving patient outcomes in epilepsy and addiction treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile